SARS-CoV-2 spike-dependent platelet activation in COVID-19 vaccine-induced thrombocytopenia
Blood Adv
.
2022 Apr 12;6(7):2250-2253.
doi: 10.1182/bloodadvances.2021005050.
Authors
Jacob Appelbaum
1
,
Donald M Arnold
2
,
John G Kelton
2
,
Terry Gernsheimer
1
,
Stefan D Jevtic
2
,
Nikola Ivetic
2
,
James W Smith
2
,
Ishac Nazy
2
Affiliations
1
Division of Hematology, Department of Medicine, University of Washington School of Medicine, Seattle, WA; and.
2
Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada.
PMID:
34724709
PMCID:
PMC8563079
DOI:
10.1182/bloodadvances.2021005050
No abstract available
Publication types
Research Support, Non-U.S. Gov't
MeSH terms
COVID-19 Vaccines / adverse effects
COVID-19*
Humans
Platelet Activation
SARS-CoV-2
Thrombocytopenia* / chemically induced
Substances
COVID-19 Vaccines
Grants and funding
T32 HL007093/HL/NHLBI NIH HHS/United States